Using Targeted Virotherapy to Treat a Resistant Ewing Sarcoma Model: From the Bedside to the Bench and Back
Metastatic Ewing sarcoma (EWS) is often resistant to current multimodal chemotherapeutic regimens. Oncolytic virus therapy (OV) is a novel therapeutic platform whereby viruses can selectively infect as well as replicate in and kill tumor cells, while sparing normal tissues. The purpose of this study...
Saved in:
Main Authors: | Hesham Abdelbary, Christopher W. Brown, Joel Werier, John Bell |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1155/2014/171439 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tuberculosis in the 1990s: From Bedside to Bench and Back
by: Frances B Jamieson, et al.
Published: (1999-01-01) -
Bench to Bedside : diagnostic microbiology for the clinicians /
Published: (2018) -
Novel Therapeutic Targets in Metabolic Disorders: From the Bench to the Bedside
by: Maddalena Illario, et al.
Published: (2014-01-01) -
Nutrition: From Bench to Bedside
by: Naim A. Khan, et al.
Published: (2016-01-01) -
Mitochondrial-targeted therapies in traumatic brain injury: From bench to bedside
by: Sidra Tabassum, et al.
Published: (2025-01-01)